Related Experiment Video
Updated: Jul 10, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Modulation of the p53-MDM2 interaction by phosphorylation of Thr18: a computational study
Hui Jun Lee1, Deepa Srinivasan, David Coomber
1Bioinformatics Institute, Singapore.
Abstract:
The transcription factor p53 is under negative regulation by the ubiquitin ligase MDM2 and its close homologue MDM4. In the bound complex between MDM2 and p53, the transactivation domain of p53 adopts an amphipathic helical conformation which optimizes the spatial organization of three key hydrophobic residues (Phe19, Trp23, Leu26) for maximum interactions. The interaction with MDM2 is known to be abrogated by phosphorylation of Ser/Thr residues in the MDM2 N-terminal domain and in the p53 transactivation domain. In the latter, phosphorylation of Thr18 has been attributed to destabilize a key hbond between Thr18 and Asp21. This interaction has been thought to be critical for the formation of the helical conformation of the p53 transactivation domain. Molecular dynamics simulations of the p53 transactivation domain suggest that phosphorylation of either Thr18 or Ser20 does not disrupt its helical structure but does result in reduced affinities for MDM2. While interactions between the Thr18 and Asp21 are indeed broken due to charge-charge repulsions, the peptide has enough inherent flexibility to form alternate patterns of hbonds, resulting in the maintenance of helicity. Electrostatics of MDM2 reveal local anionic patches in the region where Thr18 docks. These suggest that repulsions will arise because the MDM2 surface will force the p53 to bind in a manner that will place the negatively charged phosphorylated Thr18 near this anionic region. A similar, albeit somewhat attenuated pattern of electrostatic modulations, is seen for a model of MDM4 that has been built. Mutants of MDM2 and MDM4 have been designed to attenuate this anionicity and have been computationally demonstrated to enhance the binding of the phosphorylated peptides.
Insights
Phosphorylation of the p53 protein does not disrupt its helical structure but reduces binding affinity to MDM2. Modifying MDM2 and MDM4 electrostatic properties enhances binding of phosphorylated p53.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- The tumor suppressor protein p53 is regulated by ubiquitin ligases MDM2 and MDM4.
- p53's transactivation domain adopts a helical structure upon binding MDM2, involving key hydrophobic residues.
- Phosphorylation of p53 and MDM2 can disrupt their interaction.
Purpose of the Study:
- To investigate the structural and binding effects of p53 transactivation domain phosphorylation.
- To explore the role of electrostatic interactions in p53-MDM2/MDM4 binding.
- To computationally design MDM2/MDM4 mutants for enhanced p53 binding.
Main Methods:
- Molecular dynamics simulations of the p53 transactivation domain.
- Analysis of hydrogen bonding and helical structure.
- Computational modeling of MDM2 and MDM4 electrostatics.
- Design and in silico testing of MDM2/MDM4 mutants.
Main Results:
- Phosphorylation of Thr18 or Ser20 in p53 does not disrupt its helical conformation.
- Phosphorylation leads to reduced binding affinity between p53 and MDM2.
- Charge-repulsion between phosphorylated Thr18 and anionic patches on MDM2 hinders binding.
- Mutants of MDM2 and MDM4 designed to reduce anionicity enhance binding of phosphorylated p53.
Conclusions:
- p53 helicity is maintained despite phosphorylation, but binding affinity is reduced due to electrostatic repulsion.
- Electrostatic complementarity plays a crucial role in p53-MDM2/MDM4 interactions.
- Targeting electrostatic interactions offers a strategy to enhance binding of phosphorylated p53 to MDM2/MDM4.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules

